• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail

  • Print
  • Share
  • E-mail
Approval Date:  03/17/2011
Trade Name:  Alimta
Generic or Proper Name (*):  pemetrexed disodium
Indications Studied:  Refractory and recurrent solid tumors, including osteosarcoma, Ewing sarcoma/peripheral PNET, rhabdomyosarcoma, and neuroblastoma
Therapeutic Category:  Antineoplastic
Ages Studied:  >12 months and d21 years
Study #:  1
Study Type:  Pharmacokinetic
Study Design:  Open Label
No Patients:  33
No Centers:  14
No Countries:  2
Countries:  US, Canada